On September 6, 2021 Alliance Pharma plc (AIM: APH), the international healthcare group, reported that it will announce its results for the six months ended 30 June 2021 on Tuesday 21 September 2021 (Press release, Alliance Pharma, SEP 6, 2021, View Source;aph-/rns/notification-of-half-year-results/202109060700077459K/ [SID1234587273]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A link to a recorded presentation of the half year results, by Peter Butterfield, Chief Executive Officer, and Andrew Franklin, Chief Financial Officer, will be included in the results announcement.

The recorded presentation will also be made available at the investor section of Alliance’s website, View Source .

A Q&A call for analysts will be held at 10.00am on the day of the results, 21 September 2021; analysts who require joining details should contact Buchanan at [email protected] .

For any further information, please contact Buchanan at the details below.